Tumour-based DNA methylation markers of breast cancer survival: a pooled analysis of 2157 cases
Elaheh Zarean, Shuai Li, Enes Makalic, Roger L. Milne, Graham G. Giles, Catriona McLean, Melissa C. Southey, Pierre-Antoine Dugué · 2026
Read Tumour-based DNA methylation markers of breast cancer survival: a pooled analysis of 2157 cases by Elaheh Zarean, Shuai Li, Enes Makalic, Roger L. Milne, Graham G. Giles, Catriona McLean, Melissa C. Southey, Pierre-Antoine Dugué (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13579885.txt.
Description
Elaheh Zarean and colleagues hunt DNA methylation marks that forecast breast cancer survival, in a 2026 pooled study of 2,157 tumors. Methylation is a chemical tag layer on DNA that can silence genes. Data came from a Melbourne cohort plus nine public sets, and the scan covered five year survival in close to two thousand cases.
Thousands of tag sites linked to survival before adjustment, and hundreds held after hormone receptor status was counted. A signature built from 228 sites sharpened five year forecasts beyond standard clinic facts in the test cohort. The same score also predicted cancer free time in a harder to treat tumor subgroup. Pathway checks pointed to the biology under those tags, and the authors pitch the score for risk talks after diagnosis.
Catalog record
| CREATOR | Elaheh Zarean, Shuai Li, Enes Makalic, Roger L. Milne, Graham G. Giles, Catriona McLean, Melissa C. Southey, Pierre-Antoine Dugué |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52343 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |